CORONAVIRUS Q AND A IS WHAT WE CALL THIS SEGMENT WHERE WE SEPARATE THE FACTS FROM THE
FEAR THAT ARE OUT THERE AND ASK
YOUR QUESTIONS AND OUR
QUESTIONS.
>> STEVE SPRIESTER: SURROUNDING
COVID-19 AND WE’RE VERY HAPPY TO HAVE THE PRESIDENT AND CEO FROM THE TEXAS BIOMEDICAL
RESEARCH INSTITUTE DOCTOR LARRY
SCHLESINGER
WITH US DOCTOR THANK YOU FOR
BEING HERE WITH US AND I KNOW
YOU KNOW A LOT ABOUT VACCINES
THAT ARE IN DEVELOPMENT.
SOME THINGS THAT HAVE BIT
BETTER OUT THERE WHEN IT COMES
TO A TIMELINE DO YOU THINK BY
THE END OF THE YEAR IS
REALISTIC.
>> THANK YOU THAT IT’S GOOD TO
BE I
HAVING A VACCINE
THAT CENTER.
>> BROADLY ARE TO THE PUBLIC
UNDER THIS YEAR IS HIGHLY
AMBITIOUS.
>> AND NOT LIKELY.
I.
>> HAVING SAID THAT I’M ON VERY
HELPFUL. THERE WE WILL HAVE A.
>> I THINK SOME OF THAT
DATA FROM PHASE ONE CLINICAL TRIAL. A LITTLE BIT EVERY NOW AND IT’S NOT MUCH YOUR DAUGHTER
AND SOME OF THE
I STARTED IS THAT ARE OUT
THERE.
SUGGESTED THAT WE WILL ARE
CONSISTENT WITH AND THE FACT
THAT WE WILL HAVE A BACK SEAT.
BUTTER THERE’S A LONG WAY
TO GO. WE’RE REALLY JUST
THE BEGINNING. ALTHOUGH THERE
IS TRULY A LOT OF ENERGY AROUND
THE SUN AND
WE HEAR ABOUT A VERY FREQUENTLY
I THINK IT’S GOING TO TAKE WORK
TIME. 2 WE FULLY. THERE
A LEAD A CANDIDATE VACCINE THAT
WORKS FOR THE MAJORITY
OF PEOPLE AND THERE WE HANDLE
ALL THE DETAIL MANUFACTURING
CROSS THE SEAS NECESSARY TOO
BROADLY DISTRIBUTED REXY DOCTOR
CAN YOU.
CAN YOU. >> TALK TO US ABOUT THE ROLE THAT SAN ANTONIO IS PLAYING IN
ALL THIS.
>> WELL I THINK SAN ANTONIO HAS
A LOT OF SCIENCE GOING ON
RIGHT NOW AIR IT WAS A RANGER
PROJECTS
GOING ON ON TEXAS PALMER
RESEARCH INSTITUTE’S MISSION IS
TO PROTECT THE PUBLIC FROM
INFECTIOUS DISEASES AND WE HAVE
ABOUT 40 INDIVIDUAL STAFF AND FACULTY ARE INVOLVED IN STUDIES ARE OUR PRIMARY STUDIES ARE
BEING IN FURTHER DEVELOPMENT OF
THOSE ANIMAL MODELS. YOU
AND I TO BE USED IN TESTING
THERAPIES AND VACCINES
IN WHERE JUST COMPLETING OUR
FIRST MAJOR STUDY AND BEING
WRITTEN UP FOR PUBLICATION
REALLY IN THE NEXT WEEK OR 2
YOU’LL BE HEARING MORE
ABOUT IT AND WHAT WE’RE
LEARNING IS THAT THE IMMUNE
RISKY THE IMMUNE RESPONSE TO
COVID-19 YEARS WERE COMPLEX IN
JUST IN TOO MUCH.
EVERYBODY’S ARE PRODUCED BY
CELLS AND WE’RE LEARNING A LOT
OF WORK TO HELP THE CELLS
RESPONSIBLE
ARE SO AND WE’RE REALLY IN A
PRIME POSITION WITH BOTH
PRIVATE MODELS AND SMALL ANIMAL
MODELS RODENT MODELS
TO BE ABLE TO TEST A VARIETY OF
THERAPIES AND VACCINES AND WE
HAVE A NUMBER OF PARTNERS NEAR
A 100. THERE ARE
WORKING WITH A NUMBER OF THESE
TYPES
OF STARS. NOW WE PARTNER WITH
ON DUTY HEALTH SAN ANTONIO UTSA
AND START WITH RESEARCH
INSTITUTE. WE’RE ALSO PLAYING A
ROLE IN THE MEDICAL SCHOOL IS
INVOLVED IN SOME MULTI CENTER
CLINICAL TRIALS, PARTICULARLY
LOOKING AT US AIR THESE
COMBINATION THERAPIES FOR
COVID-19 WE’RE GUESSING HERE
ARE SOME OTHER ROUTES. SO
WE ARE PATIENTS STARTED
RESEARCH GOING ON IN THE CITY.
AND WE ALSO HAVE DRUG
DISCOVERY. GOING ON THROUGH
WORK AT UTSA AND STARTS
RESEARCH INSTITUTE USING THE
TECHNOLOGIES THEY HAVE
AVAILABLE AND THE GOOD NEWS IS
WE’RE PARTNERING WITH EACH
OTHER
THEY’RE EFFECTIVELY THROUGH AN
ENTITY CALLED SENATORIAL
PARTNERSHIP FOR PRECISION
THERAPEUTICS. VERY EXCITED
ABOUT THIS AS THEY ARE
WE’RE LIVE. A PARTNERSHIP AMONG
THE MAJOR RESEARCH INSTITUTE
BUT ALSO
THE PRIVATE SECTOR HAS A ROLE
TO PLAY IN OUR AVERAGE GLOBAL
IS DOING SOME STUDIES WITH
REGARD TO US THAT THERE BE.
SO WHEN YOU PUT IT ALL
TOGETHER. I THINK WE HAVE A
VERY BROAD SCOPE AND WE HAVE AN
OPPORTUNITY TO MAKE A
DIFFERENCE TO
PEOPLE’S LIVES.
>> STEVE SPRIESTER: YOU KNOW IT
SEEMS LIKE WE’RE LEARNING SO
MUCH ABOUT THIS DISEASE, YOU
KNOW ON A DAY BY DAY BASIS AND
I KNOW THAT
YOUR BACKGROUND. IS INFECTIOUS
DISEASE. I KNOW THAT
TUBERCULOSIS AND AND LONGS FOR
YOU ESPECIALLY ARE YOU ARE YOU ARE INTRIGUED BY HOW THIS DISEASE APPEARS TO BE AFFECTING
PEOPLE’S LUNG FUNCTION.
>> WELL YES, I THINK THERE I THINK YOU KNOW I THINK WE’RE TO PHASE WHERE WE’RE LEARNING A
LOT
EVERY DAY.
>> AND I THINK SOME OF THE
CRITICAL FEATURES OF THIS
DISEASE CONTINUE TO BE A
INTEREST ME AS THE YEARS I MEAN
THE
FACT THAT A NUMBER OF PEOPLE
WHO ARE EXPECTED TO REMAIN
ASYMPTOMATIC AND IT DOES APPEAR
THROUGH THE RESEARCH THE FIRES
STATES ARE IN THE UPPER
AIRWAYS. THIS IS WHERE A LOT OF
THE PERSISTENCE OCCURS. BUT
THERE ARE A SUBSET OF
INDIVIDUALS WHO
I’VE BECOME CRITICALLY ILL WERE
ON VENTILATORS AND THEY’RE NOT
ALL JUST OLDER INDIVIDUALS OR THOSE WITH OTHER DISEASES LIKE TYPE II SOME YOUNG PEOPLE AS
WELL, ALTHOUGH IT’S MORE COMMON
IN OLDER INDIVIDUALS. I WANT
TO SEIZE. BUT THIS IS
ALL ABOUT THE FACT THAT WE AS
HUMANS ARE VERY DIVERSE IMMUNE
SYSTEM. AND OUR REACTION TO ANY
FOREIGNER INVADER IN THIS CASE
COVID-19. IS
IS VARIABLE. WE’RE HEARING ABOUT CLOTTING DISORDERS AND NOW WE HAVE THIS VERY
WORRISOME. ALTHOUGH RARE OKAY
SHE CHILDREN WITH THE SYSTEMIC
DISORDER AND THIS IS TELLING US
A BIT MORE
SO HOPE RESCUE
MINERS OR YOU KNOW THEY’RE GOOD
ENOUGH BODIES TO PROTECT US.
BUT THEY’RE ALSO THE ONES THAT
MAY BE CONTRIBUTING TO THIS
HYPER. THE IN RESPONSE.
SO I THINK THERE ARE A NUMBER
OF AIR AND THROUGH FEATURES
WE’RE LEARNING ABOUT THE
RESPONSE WHILE WE’RE TRYING TO
CREATE A BACK SEAT.
THAT’S UNPRECEDENTED. THE OTHER
REPORT, IT’S UNUSUAL IS
THE FACTOR. THAT’S A 24 7 NEWS
CYCLE AND THERE WERE CARS WHICH
IS A PUBLIC REPOSITORY FOR
NON-PEER REVIEWED.
PAPERS THERE’S A LOT OF
INFORMATION BUT IT’S EARLY
INFORMATION AND I REALLY THINK
WE NEED TO TAKE PAUSE AND
CONTINUE TO EDUCATE
THE PUBLIC. AND WHAT IS CIRCLE
EDITOR PEER REVIEWED THOROUGHLY
OR I WAITED. VERSUS JUST SOME
COATES ARE THEY ARE NOT REALLY
SURE WHAT
TO ME.
>> SOME FASCINATING INFORMATION
THERE FROM DOCTOR LARRY
SLASHING HER THANK YOU SO MUCH
FOR JOINING US.